Prelude Capital Management’s Astrana Health ASTH Stock Holding History
Bought
Maintained
Sold
Other funds holding ASTH
Prelude Capital Management's ASTH Position: Q3 2026 in Review
Prelude Capital Management sold out of Astrana Health (ASTH) in Q3 2026, closing a stake of 4,843 shares — an estimated $225K sold.
Prelude Capital Management first reported a position in ASTH in Q3 2018 and held it in 7 quarters. The position peaked at $1.35M in Q3 2021. 218 funds tracked by Wall St. Rank hold ASTH as of Q3 2026.
- Prelude Capital Management reported no remaining Astrana Health position as of Q3 2026 after selling out during the quarter.
- Prelude Capital Management sold 4,843 Astrana Health shares in Q3 2026, an estimated $225K.
- Prelude Capital Management first reported a position in Astrana Health in Q3 2018 and held it in 7 quarters.
- Prelude Capital Management's Astrana Health position peaked at $1.35M in Q3 2021.
- 218 funds tracked by Wall St. Rank held Astrana Health as of Q3 2026.
Based on Prelude Capital Management's 13F filing for Q3 2026, filed 16 Nov 2026.